Lenzings, Alabama

Lenzing's Alabama Bet and Heiligenkreuz Deadline: A Tale of Two Fibre Strategies

Published on 11/13/2026 at 12:32 | Editorial boerse-global.de
Lenzing unveiled a EUR 27 Mio. Lyocell investment in Mobile, Alabama, while still weighing offers for Heiligenkreuz with an end-2026 deadline.
Lenzing's Alabama Bet and Heiligenkreuz Deadline: A Tale of Two Fibre Strategies Illustration mit AI erstellt.

Lenzing is pulling in two directions at once. On the same day it unveiled a EUR 27 Mio. investment in Lyocell short-cut fibre capacity at its Mobile, Alabama site, the Austrian fibre maker confirmed it is still weighing several non-binding purchase offers for its Heiligenkreuz plant — with a hard deadline of end-2026 to decide whether a viable sale can be struck or the site shuts down at the end of the first quarter of 2027.

The Alabama commitment is part of a broader EUR 50 Mio. programme targeting the nonwovens business. Lenzing had previously earmarked EUR 23 Mio. of that envelope for its site in Lenzing itself. The Mobile expansion is designed to sharpen production flexibility and bolster specialty-fibre innovation for nonwoven applications.

Impairments Drag the Bottom Line Into the Red

The growth spending comes against a backdrop of accounting pain. Lenzing reported a loss after tax of EUR 130.3 Mio. on 5 November, weighed down by non-cash impairments of EUR 136.1 Mio. tied to the Heiligenkreuz and Grimsby sites.

Those write-downs pushed EBIT to minus EUR 55.1 Mio. for the first nine months of 2026. Unadjusted EBITDA came in at EUR 316.4 Mio., a figure that already absorbed EUR 36.6 Mio. in restructuring charges.

Should investors sell immediately? Or is it worth buying Lenzing?

Underlying Profitability Holds Firm

Strip out the one-offs and the picture brightens. Adjusted EBITDA for the nine-month period reached EUR 353.0 Mio., essentially flat year on year, even as revenue slipped 2.3% to EUR 1.93 Mrd. The adjusted EBITDA margin, meanwhile, edged up to 18.3% from 17.9% in the prior-year period.

For the full year 2026, management is guiding toward adjusted EBITDA of between EUR 430 Mio. and EUR 460 Mio.

Heiligenkreuz Hangs in the Balance

The sale process for Heiligenkreuz, first reported by Der Standard, will advance only with bidders whose offers point to an economically sustainable future for the site. Should no workable deal materialise by the end of 2026, the plant will close at the end of the first quarter of 2027 as previously outlined.

Lenzing at a turning point? This analysis reveals what investors need to know now.

The twin-track approach — investing in US specialty fibre capacity while restructuring European assets — defines Lenzing's current playbook: spend where growth is visible, and set a firm exit timetable where it is not.

Ad

Lenzing Stock: New Analysis - 13 November

Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Lenzing analysis...

Disclaimer...
en | AT0000644505 | LENZINGS | boerse | 70504206 |